Stay updated on Nivolumab for Squamous Dysplasia Reversal Clinical Trial
Sign up to get notified when there's something new on the Nivolumab for Squamous Dysplasia Reversal Clinical Trial page.

Latest updates to the Nivolumab for Squamous Dysplasia Reversal Clinical Trial page
- Check6 days agoChange DetectedThe footer’s site revision changed from v3.7.0 to v3.7.1 while the page continued to show a 403 error.SummaryDifference0.2%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedThe study page now shows a 403 Forbidden error instead of the study details, indicating the record is temporarily inaccessible.SummaryDifference19%

- Check48 days agoChange DetectedThe page's revision tag was updated from v3.6.5 to v3.6.6, indicating a minor version update to the page rather than a change to study details.SummaryDifference0.1%

- Check62 days agoChange DetectedThe page now includes the Study Protocol and Statistical Analysis Plan PDF and related study documents, along with updated record history and metadata; it also lists investigators, collaborators, and site locations, providing fuller context for the NCT03347838 study.SummaryDifference54%

- Check69 days agoChange DetectedRevision tag updated from v3.6.4 to v3.6.5, signaling an administrative update to the study record rather than changes to trial details.SummaryDifference0.1%

- Check83 days agoChange DetectedRevision tag updated from v3.6.3 to v3.6.4 on the page, indicating a minor update to the page template. The study details and user-facing content remain unchanged.SummaryDifference0.1%

Stay in the know with updates to Nivolumab for Squamous Dysplasia Reversal Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab for Squamous Dysplasia Reversal Clinical Trial page.